Mushiroi T, Shibahara R, Tamura M, Shimizu T, Itoh Y, Ukai Y, Yoshikuni Y, Kimura K
Research Laboratories, Nippon Shinyaku Co. Ltd., Kyoto, Japan.
Nihon Yakurigaku Zasshi. 1996 May;107(5):237-45. doi: 10.1254/fpj.107.237.
Effects of a novel TRH analog, montirelin hydrate (NS-3), on the coma caused by head concussion and narcosis induced by pentobarbital were compared with those of TRH in mice. Head concussion caused a behavioral comatose state with loss of the righting reflex and spontaneous motor activity. NS-3 shortened the latent periods to the recovery of the righting reflex (0.03-0.1 mg/kg, i.v.) and spontaneous motor activity (0.1 mg/kg, i.v.) following the head concussion. In the case of TRH, higher doses were needed to induce such effects. NS-3 (0.1-0.3 mg/kg, i.v.) reversed the pentobarbital-induced narcosis in a dose-dependent manner. A similar effect was elicited by 30- to 100-fold higher doses of TRH than NS-3. The analeptic effect of NS-3 in the pentobarbital-narcotized mice was antagonized by SCH23390, a dopamine D1 antagonist or by the combined treatment with prazosin and scopolamine, while neither prazosin nor scopolamine alone antagonized the analeptic effect of NS-3. Taken together with the finding that NS-3 did not bind to dopamine, adrenaline or muscarine receptors, it is suggested that NS-3 may restore the disturbance of consciousness by activating the brain dopamine, noradrenaline and acetylcholine neurons without stimulating these receptors directly.
将新型促甲状腺激素释放激素类似物水合莫替瑞林(NS-3)与促甲状腺激素(TRH)对小鼠脑震荡所致昏迷及戊巴比妥诱导麻醉的影响进行了比较。脑震荡导致行为性昏迷状态,伴有翻正反射和自发运动活动丧失。NS-3缩短了脑震荡后翻正反射恢复的潜伏期(静脉注射0.03 - 0.1 mg/kg)和自发运动活动恢复的潜伏期(静脉注射0.1 mg/kg)。对于TRH而言,需要更高剂量才能产生此类效果。NS-3(静脉注射0.1 - 0.3 mg/kg)以剂量依赖性方式逆转戊巴比妥诱导的麻醉。TRH产生类似效果所需剂量比NS-3高30至100倍。多巴胺D1拮抗剂SCH23390或哌唑嗪与东莨菪碱联合处理可拮抗NS-3对戊巴比妥麻醉小鼠的苏醒作用,而单独使用哌唑嗪或东莨菪碱均不能拮抗NS-3的苏醒作用。结合NS-3不与多巴胺、肾上腺素或毒蕈碱受体结合这一发现,提示NS-3可能通过激活脑内多巴胺、去甲肾上腺素和乙酰胆碱能神经元而不直接刺激这些受体来恢复意识障碍。